Aspirin desensitization improves alcohol-induced allergies in patients with underlying respiratory disease

July 10, 2018, Perelman School of Medicine at the University of Pennsylvania

Patients who suffer from Aspirin Exacerbated Respiratory Disease (AERD) often experience an additional allergic reaction when drinking alcohol, including nasal congestion, wheezing, and a runny nose. Now a new study led by researchers in the Perelman School of Medicine at the University of Pennsylvania finds a common treatment for AERD—aspirin desensitization—can also help alleviate the alcohol-induced symptoms of the condition. The researchers, led by John V. Bosso, MD, director of the Otorhinolaryngology Allergy Clinic and medical director of the Penn AERD Center, published their findings in the journal International Forum of Allergy and Rhinology today.

AERD, also known as Samter's Triad, is a chronic inflammatory disease involving nose, sinuses, and lungs. These patients suffer from nasal polyps, severe sinusitis, and asthma. It also involves a newly-formed sensitivity to and other non-steroidal anti-inflammatory drugs (NSAIDs). These drugs would normally be used to treat the other symptoms, but are now no longer an option due to the patient's new allergy.

A common approach to this problem involves aspirin desensitization, in which an allergist gives a patient gradually-increasing doses of aspirin to help the patient overcome the sensitivity. By becoming desensitized to aspirin and then taking it for long-term therapy, there is a significant reduction in the regrowth of any new inflammatory polyp disease. This results in fewer future surgeries, less need for prednisone and antibiotics, and fewer asthma attacks. Patients also often report an improved sense of smell, which is often the most distressing problem they face due to AERD.

Penn's approach is uniquely multidisciplinary in that it also involves surgery to remove any pre-existing that have formed as a result of AERD. It is the only such multidisciplinary AERD center in the world.

"Without the surgery, the aspirin desensitization would leave the previously established inflammatory disease untreated, and without the work of the allergist, the polyps would return, so the dual approach is critical," Bosso said.

In this study, Bosso and his team evaluated 37 AERD patients who underwent both surgery and aspirin desensitization. Patients were enrolled between October of 2015 and October of 2017 at both Penn and Scripps Clinic Carmel Valley in California. Before treatment, 78 percent of patients said they could only tolerate alcohol about half the time or less, while 42 percent said they never or almost never were able. The most common symptoms associated with were (97 percent), a (47 percent), and wheezing (40 percent). The majority of patients said these symptoms were brought on by as little as one to three glasses of wine in and as quickly as 15 minutes to an hour.

Following aspirin desensitization, 86.5 percent of patients said they could drink alcohol without experiencing these symptoms, and 70 percent of patients described the desensitization as "very helpful" or "extremely helpful" for their ability to tolerate alcohol. Only four patients noted no improvement in their symptoms. Patients also reported it took more alcohol or a longer period of time for these symptoms to occur.

"AERD can severely affect a patient's quality of life, and when you combine the findings of this study with the clinical outcomes we can achieve, it shows aspirin desensitization can considerably improve quality of life for those who undergo it," Bosso said.

Bosso notes that the study is not without its limitations, including the lack of a control group for comparison. Further, seven patients enrolled in the study but were not included for evaluation after they couldn't complete the treatment due to adverse reactions such as gastrointestinal problems.

"It's important for patients to be aware of the possible benefits and drawbacks of undergoing aspirin desensitization, and these findings may help inform ' decisions," Bosso said.

Explore further: Take two aspirin and make sure you're not allergic

Related Stories

Take two aspirin and make sure you're not allergic

November 5, 2015
Many patients with cardiovascular disease are treated with aspirin because it is effective, low-cost and has few side effects. Some patients who have a reaction to aspirin are told they are allergic without being tested by ...

Aspirin use doesn't cut cancer incidence in older T2DM patients

June 25, 2018
(HealthDay)—For Japanese patients with type 2 diabetes, low-dose aspirin is not associated with reduced cancer incidence, except in those younger than 65 years, according to a study published online June 16 in Diabetes ...

Study shows taking aspirin before or after coronary artery bypass graft is associated with a lower risk of death

June 4, 2018
New research presented at this year's Euroanaesthesia congress in Copenhagen, Denmark shows that in patients undergoing a coronary artery bypass graft (CABG) surgery, taking aspirin before and after surgery is associated ...

Ticagrelor + aspirin beneficial after elective CABG

April 25, 2018
(HealthDay)—For patients undergoing elective coronary artery bypass grafting (CABG), ticagrelor + aspirin is associated with significantly increased saphenous vein graft patency rates compared with aspirin alone, according ...

Aspirin therapy appears safe before thyroid surgery

March 7, 2018
(HealthDay)—Continuing aspirin therapy before thyroid surgery does not appear to increase the risk of intraoperative bleeding, according to a study published online March 1 in JAMA Otolaryngology-Head & Neck Surgery.

PFA-100-measured aspirin resistance linked to CV events

October 31, 2017
(HealthDay)—Aspirin resistance, measured using the Platelet Function Analyzer (PFA)-100 system, is associated with cardiovascular events in aspirin-treated patients, according to a study published online Oct. 21 in the ...

Recommended for you

Yeast species used in food industry causes disease in humans

July 19, 2018
A major cause of drug-resistant clinical yeast infections is the same species previously regarded as non-pathogenic and commonly used in the biotechnology and food industries. The study, published on July 19th in the open-access ...

Deadly Rift Valley fever: New insight, and hope for the future

July 19, 2018
Health control measures alone could be ineffective in the long term fight against the deadly Rift Valley fever which affects both humans and animals, a new study in the journal PNAS reports.

New guidelines to diagnose, manage rare endocrine disorders

July 19, 2018
International guidelines have been published for the first time to help doctors around the globe diagnose and manage patients with a very rare set of endocrine diseases known as pseudohypoparathyroidism and its related disorders, ...

Overuse of antibiotics not what the doctor ordered

July 19, 2018
With increased use of antibiotics worldwide linked to growing antibiotic resistance, a world-first study co-authored by a QUT researcher has highlighted the growing impact of non-prescription supply of antibiotics in community ...

Alcohol-related cirrhosis deaths skyrocket in young adults

July 18, 2018
Deaths from cirrhosis rose in all but one state between 1999-2016, with increases seen most often among young adults, a new study shows.

Hidden blood in feces may signal deadly conditions

July 17, 2018
(HealthDay)—Even if it's not visible to the naked eye, blood in the stool can be serious—a sign of a potentially fatal disease other than colon cancer, new research suggests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.